Skip to main content

Table 6 Data and recovery profiles in perioperative period of anesthesia

From: Cost-effectiveness of anesthesia maintained with sevoflurane or propofol with and without additional monitoring: a prospective, randomized controlled trial

 

SEVO (n = 30)

SEVO+ (n = 30)

p value

PROP (n = 30)

PROP+ (n = 29)

p value

Length of anesthesia (min)

140.7 ± 55.5

137.0 ± 53.0

0.998

115.8 ± 53.4

124.4 ± 54.9

0.997

Length of surgery (min)

99.7 ± 51.5

103.5 ± 49.0

1.000

81.2 ± 46.2

89.2 ± 51.0

1.000

Time to extubation (min)

14.5 ± 3.9

11.1 ± 4.7

0.002

15.2 ± 4.7

12.6 ± 5.4

< 0.001

PONV

1(3.3%)

2(6.7%)

0.990

1(3.3%)

1(3.5%)

1.000

Other minor complications

13(43.3%)

13(43.3%)

1.000

3(10.0%)

7(24.1%)

1.000

Time to MAP restoration (min)

15.2 ± 7.6

12.3 ± 6.0

0.517

17.2 ± 9.5

11.1 ± 10.0

0.076

Length of patient stay in recovery room (min)

69.5 ± 37.9

63.8 ± 16.1

0.454

64.3 ± 29.7

62.8 ± 12.4

0.799

  1. Values are expressed as mean ± standard deviation; SEVO Sevoflurane anesthesia without additional monitoring; SEVO+ Sevoflurane anesthesia with BIS and TOF monitoring; PROP Propofol anesthesia without additional monitoring; PROP+ Propofol anesthesia with BIS and TOF monitoring; PONV Postoperative nausea and vomiting; Other minor complications Sore throat, headache, drowsiness, dizziness, cognitive dysfunction, memory loss, vision problems, shivering, and myalgia; Other minor complications are the number of patients and incidence rates (%); MAP = mean arterial blood pressure